Durvalumab and Radiation for Chemotherapy-Ineligible Advanced NSCLC
Recent clinical data indicates that combining Durvalumab with radiation therapy offers a viable treatment pathway for patients with locally advanced non-small cell lung cancer (NSCLC) who cannot tolerate chemotherapy. This ... Read More